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Abstract
Background: The Salmonella AvrA gene is present in 80% of Salmonella enterica serovar strains. AvrA protein
mimics the activities of some eukaryotic proteins and uses these activities to the pathogen’s advantage by
debilitating the target cells, such as intestinal epithelial cells. Therefore, it is important to understand how AvrA
works in targeting eukaryotic signaling pathways in intestinal infection in vivo. In this study, we hypothesized that
AvrA interacts with multiple stress pathways in eukaryotic cells to manipulate the host defense system. A whole
genome approach combined with bioinformatics assays was used to investigate the in vivo genetic responses of
the mouse colon to Salmonella with or without AvrA protein expression in the early stage (8 hours) and late stage
(4 days). Specifically, we examined the gene expression profiles in mouse colon as it responded to pathogenic
Salmonella stain SL1344 (with AvrA expression) or SB1117 (without AvrA expression).
Results: We identified the eukaryotic targets of AvrA and the cell signaling pathways regulated by AvrA in vivo.W e
found that pathways, such as mTOR, NF-kappaB, platelet-derived growth factors, vascular endothelial growth factor,
oxidative phosphorylation, and mitogen-activated protein kinase signaling are specifically regulated by AvrA in vivo
and are associated with inflammation, anti-apoptosis, and proliferation. At the early stage of Salmonella infection,
AvrA mainly targeted pathways related to nuclear receptor signaling and oxidative phosphorylation. At the late
stage of Salmonella infection, AvrA is associated with interferon-gamma responses.
Conclusion: Both early and late phases of the host response exhibit remarkable specificity for the AvrA+
Salmonella. Our studies provide new insights into the eukaryotic molecular cascade that combats Salmonella-
associated intestinal infection in vivo.
Background
The capacity of pathogenic Salmonella to infect their
hosts is often dependent on the ability of Salmonella to
inject virulent factors directly into the host cell cytosol
through the type-three secretion system (TTSS). These
injected bacterial proteins, called effectors, are of special
interest in studies of host-pathogen interactions because
effectors can manipulate host cell function [1,2]. The
effectors often have unique functions suited to a parti-
cular pathogen’s infection strategy.
AvrA is a Salmonella effector that is translocated into
host cells [3]. The AvrA gene is present in 80% of
Salmonella enterica serovar Typhimurium strains [4].
Previous studies show that AvrA related family members
include Yersinia virulence factor, YopJ, and the Xantho-
monas campestris pv.vesicatoria protein, AvrBsT [5].
Analysis with MEROPS database shows that AvrA
belongs to YopJ-like proteins and genes (family C55) in
bacterial species (see details in http://merops.sanger.ac.
uk). Many studies highlight the remarkable complexity
of the TTSS system and AvrA’s function. Studies show
that AvrA possesses enzyme activities to remove the
ubiquitins from IBa and b-catenin, to transfer acetyl to
inhibit JNK activity and to bind with Erk2 and MKK7
[6-9]. Although AvrA is known to regulate diverse bac-
terial-host interactions, the eukaryotic targets of AvrA
are still not completely identified.
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that has been used to expand the understanding of
host-pathogen interactions. A number of reports have
described host transcriptional responses to bacterial
infection using microarrays [9-14], but the global phy-
siological function of Salmonella effector protein AvrA
in vivo is unclear. A whole genome approach, combined
with bioinformatics assays, is needed to elucidate the
in vivo genetic responses of the mouse colon to Salmo-
nella, and particularly to effector protein AvrA.
In this study, we hypothesized that AvrA interacts
with multiple pathways in eukaryotic cells to manipulate
the host defense system. A central feature of S.T y p h i -
murium pathogenesis is its ability to induce intestinal
inflammation [9]. Hence, we specifically examined the
gene expression profiles in mouse colon when it
responded to pathogenic Salmonella stain SL1344 (with
AvrA expression) or SB1117 (without AvrA expression).
SB1117 is an AvrA mutant strain derived from SL1344.
We focused on the intestinal responses to Salmonella
infection at the early phase (8 hours) and the late phase
(4 days). Ingenuity Pathways Analysis (IPA) was used to
search for networks of biologically related genes that
were co-regulated or differentially regulated in response
to SL1344(AvrA+) and SB1117 (AvrA-). The gene
expression differences found with the microarray were
confirmed using real-time quantitative reverse transcrip-
tion PCR (qRT-PCR). We identified the eukaryotic cell
targets of AvrA and confirmed the eukaryotic cell sig-
naling pathways targeted by bacterial effector protein
AvrA. These studies underscore the importance of
the Salmonella effector AvrA in intestinal-bacterial
interactions.
Methods
Bacterial strains and growth conditions
Salmonella typhimurium wild-type strain SL1344 (WT)
and Salmonella AvrA mutant strain SB1117 derived
from SL1344 (provided by Dr. Galan) [3,9]. Non-agitated
microaerophilic bacterial cultures were prepared by
inoculating 10 ml of Luria-Bertani broth with 0.01 ml of
a stationary phase culture, followed by overnight incuba-
tion (~18 h) at 37°C as previously described [15,16].
Streptomycin pre-treated mouse model
Animal experiments were performed using specific-
pathogen-free female C57BL/6 mice (Taconic, Hudson,
N Y )t h a tw e r e6 - 7w e e k so l d .T h ep r o t o c o lw a s
approved by the University of Rochester University
Committee on Animal Resources (UCAR). Water and
food were withdrawn 4 hours before oral gavage with
7.5 mg/mouse of streptomycin. Afterwards, animals
were supplied with water and food ad libitum. Twenty
hours after streptomycin treatment, water and food
were withdrawn again for 4 hours before the mice were
infected with 1 × 10
7 CFU of S. Typhimurium (100 μl
suspension in HBSS) or treated with sterile HBSS (con-
trol) by oral gavage as previously described [17]. The
wild-type Salmonella a n dA v r Am u t a n ts t r a i n sw e r ei n
t h es a m ep h a s eo fg r o w t h .M i c ew i t h o u tSalmonella
infection were set up as the control group (n = 3). At
8 hours and 4 days after infection, mice were sacrificed
and tissue samples from the intestinal tracts were
removed for analysis, as previously described [17,18].
Three independent biological replicates in every group
were performed.
Sample RNA preparation
Mice were sacrificed at 8 hours and 4 days after Salmo-
nella infection, and tissue samples from the intestinal
colon mucosa were removed. Total RNAs were isolated
using TRIzol reagent (Invitrogen) following the manu-
facturer’s protocol, followed by on-column digestion of
DNA using the RNeasy Mini Kit (Qiagen). RNA quan-
tity and quality were assessed with a Beckman Coulter
DU 640 Spectrophotometer (Beckman Coulter) and Agi-
lent 2100 Bioanalyzer (Agilent), following the manufac-
turer’s protocols.
Gene array processing and statistical analysis
The biotinylated single-stranded cDNA was prepared
from 100 ng total intact RNA extracted from Salmonella
infected mouse mucous at 8 hours and 4 days postinfec-
tion, or from uninfected mouse control samples. Mouse
cDNA was hybridized to the Mouse Gene 1.0 ST array,
a microarray chip containing 28,000 sequenced mouse
genes (Affymetrix, Santa Clara, CA).
After hybridization, the array was washed and stained
with streptavidin-phycoerythrin, and scanned in a pro-
prietary Affymetrix scanner, according to the Gene-
Chip
® Whole Transcript Sense Target Labeling Assay
manual. The fluorescence values for each feature on the
array were measured and recorded. Suite Software (Affy-
metrix) was used to produce a CEL file. The data were
processed with Expression Console (Affymetrix) using
the PLIER algorithm. The Array Assist Lite software
package was used to generate GC-RMA files (log2 trans-
formed) for each chip. All procedures were performed in
triplicate at the Functional Genome Center of the Uni-
versity of Rochester. Fold change was calculated for
each strain relative to the uninfected control. Statistical
significance (p value) was calculated by Student’s t test,
based on the results of three separate experiments.
Insignificant genes that changed by less than 1.2 fold
were removed from subsequent analysis. The 1.2 cut-off
is acceptable in the genomics analysis field [19,20].
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Degree of enrichment for cellular component, biological
processes and molecular functions was assessed by the
Gene ontology (GO) program [21].
IPA (Ingenuity Systems http://www.ingenuity.com) is a
web-based software application tool, which allows for
the mapping of gene expression data into relevant path-
ways based on their functional annotation and known
molecular interactions [22-24]. Differential expression
analyses between the normal control and Salmonella-
infected groups were carried out with GeneSifter
software.
The IPA program was used mainly for signal trans-
duction pathway analyses and generating pathway fig-
ures and tables of related candidate genes. To compare
the significant value of the canonical pathway associated
with SL1344 and SB1117 infection, we used the Canoni-
cal Pathway analysis software package in IPA software.
The significance of a given pathway in a dataset is a
measurement of the likelihood whether this pathway is
associated with the dataset by random chance. IPA soft-
ware can compare one observation to another. Within a
comparison, we could start by comparing the extent to
which the significances change from one observation to
another. Significance of the canonical pathways was
tested by the Fisher Exact test. Data from repeated
experiments were clustered within 1.2-fold changes,
indicating that the experiments produced reproducible
data.
Hierarchical Cluster analysis
After removing duplicate probe sets, a total of 904 genes
showed p-value ≤ 0.05 and estimated FC ≥1.2 at least
one of the 4 group samples pair-wise comparisons dur-
ing SL1314 and SB1117 infection respectively (SL1344
at 8 hours vs. Control, SL1344 at 4 days vs. Control,
SB1117 at 8 hours vs. Control and SB1117 at 4 days vs.
Control). This list was used to perform a hierarchical
cluster analysis and to construct a heat map using the
Gene Cluster 3.0 and tree view software (Stanford Uni-
versity, 2002).
Real-time quantitative reverse transcriptase PCR (qRT-
PCR)
Total RNA was reverse transcribed with oligoDT primer
u s i n ga nI n v i t r o g e nS u p e r S c r i p tI I Ik i t .T h ec D N Aw a s
subject to qRT-PCR using SYBR Green Supermix (Bio-
Rad). A total of 10 differentially-expressed genes in
m i c r o a r r a yd a t aw e r ec h o s e nf o rf u r t h e ra n a l y s i s .P r i -
mers of target genes are listed in Additional file 1 Table
S1. The amplification conditions were optimized for the
MJ research DNA Engine instrument, using melting
curve and electrophoresis analysis. The cycling
conditions using SYBR green detection were 95°C for
2 min, followed by 40 repetitive cycles at 95°C for 15 s,
58-60°C for 40 s, and 72°C for 30 s. A melting curve ana-
lysis was performed from 60°C to 95°C. b-actin was
selected as the endogenous control. The threshold cycle
(Ct) was determined, i.e. the cycle number at which the
fluorescence of the amplified product crosses a specific
threshold value in the exponential phase of amplification.
Relative quantification of target gene expression was eval-
uated using the comparative cycle threshold method as
previously described by Livak and Schmittgen [25].
Results and Discussion
Gene expression in the mouse colon in response to
Salmonella infection
In this study, we focused on in vivo intestinal responses
to Salmonella AvrA using the SL1344 (AvrA+) and
AvrA- strain SB1117. SL1344 is known to constitutively
express AvrA protein [3,26,27]. SB1117 lacks AvrA pro-
tein expression due to the AvrA mutation derived from
SL1344 [3,18,26]. We performed microarray hybridiza-
tion with RNA from mouse colon mucosa. Biotin-
labeled target cDNAs prepared from total RNA
extracted were hybridized to the microarray chip con-
taining 28,000 sequenced genes. We selected genes that
changed in response to Salmonella infection at 8 hours
and 4 days time points. Clustering algorithm analysis
indicated that the data generated in different arrays at
t h es a m et i m ep o i n t sw e r et i g h t l yc l u s t e r e d( d a t an o t
shown).
Cluster analysis
In order to obtain a broad overview of the changes in
gene expression during SL1344 and SB1117 infection
and identify differentially expressed genes clusters
between SL1344 infection and SB1117 infection, we gen-
erated a heat map using Gene cluster 3.0 for the 913
differentially expressed genes. As shown in Figure 1
overall, SL1344 infection and SB1117 infection showed
similar gene expression cluster at 8 hours and 4 days.
Four distinct clusters were produced: group A indicated
a repressed gene cluster at 8 hours and 4 days; group B
indicated an up-expressed gene cluster at 8 hours but a
down-expressed cluster at 4 days; group C indicated a
down-expressed gene cluster at 8 hours but an up-
expressed cluster at 4 days; group D indicated an
induced gene cluster at 8 hours and 4 days.
We further identified some subset groups (indicated
with *), which suggested that SL1344 and SB1117 infec-
tion differentially regulated genes at both the early stage
and the late stage. These results indicate that AvrA is
involved in altering host responses in the Salmonella-
intestine interaction in vivo.
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Figure 1 Hierarchical clustering analysis of 913 genes from Affymetrix array analysis showing differential expression patterns during
SL1344 (WT AvrA) infection and SB1117(AvrA-) infection. A indicates repressed gene cluster at 8 hours and 4 days; B indicates a up-
expressed gene cluster at 8 hours but a down-expressed cluster at 4 days; C indicates a down-expressed gene cluster at 8 hours but a up-
expressed cluster at 4 days; and D indicates an induced gene cluster at 8 hour and 4 days. Subset group was indicated with*. The heat map was
built by using Gene Cluster 3.0 software. Red color represents up-regulation and green shows down-regulation.
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the SL1344 and SB1117 infection groups
Our cluster analysis for the SL1344 (AvrA+) and SB1117
(AvrA-) infection groups have indicated that AvrA
expression in the Salmonella strains clearly alters the in
vivo host responses to intestinal infection. In order to
get a broad overview of the mouse colon transcriptional
changes induced by Salmonella Typhimurium SL1344
effector AvrA, fold change in gene expression was calcu-
lated for each SL1344 infection group relative to each
SB1117 infection group (Figure 2).
In the SL1344 infection group, compared to the
SB1117 infection group, at 8 hours post infection, 347
(58%) genes were up-regulated and 227 genes (42%)
were down-regulated (Figure 2 and Additional file 2
Table S2, Fold times ≥1.2 times, P ≤ 0.05). In the
SL1344 infection group at 4 days, 268 genes (44%) in
the group were up-regulated and 337 genes (56%)
were down-regulated, compared to the SB1117 infec-
tion group (Figure 2 and Additional file 3 Table S3,
Fold times ≥1.2 times, P ≤ 0.05). The majority of the
genes that were differentially expressed between
groups showed moderate alterations in expression of
1.2 to 2.0 folds (Additional file 2 Table S2 and Addi-
tional file 3 Table S3). Overall, the results indicate
that AvrA protein by TTSS must be responsible for
the induction and repression of in vivo transcriptional
reprogramming of the host cells in intestinal infection
(Figure 2).
To investigate co-regulated biological processes by
AvrA during the early and late stages of SL1344 infec-
tion, we searched co-differentially expressed genes dur-
ing the infection by using Filter datasets package of IPA
software: DNAH3 was the only annotated up-regulated
gene at both 8 hours and 4 days post infection; it is
involved in nucleotide binding, ATP binding and micro-
tubule motor activity. GRK5 (G protein-coupled recep-
t o rk i n a s e5 )w a st h eo n l ya n n o t a t e dd o w n - e x p r e s s e d
gene at both 8 hours and 4 days post infection. GRK5
p l a y sap o s i t i v er o l ei nC r o h n ’s disease [28]. Salmonella
infection increases the risko fi n f l a m m a t o r yb o w e ld i s -
eases (IBD) including Crohn’s disease [29]. It is interest-
ing to explore the potential role of AvrA in the
Salmonella-related IBD. Notch3 was annotated with
up-regulation at 8 hours post infection, but showed
down-expression at 4 days post infection. MS4A7 was
d o w n - e x p r e s s e da t8h o u r sp o s ti n f e c t i o na n du p -
expressed at 4 days post infection. These unique co-regu-
lated genes suggest that AvrA function is differentially
regulated in host cells in association with infection time.
Validation of microarray findings with real-time PCR
To validate microarray results, we selected 10 differen-
tially expressed genes between SL1344 infection group
and SB1117 infection group for qRT-PCR. All of qRT-
PCR analyses were performed in samples previously
used for the microarray experiments (Figure 3). Figure
3A and Figure 3B showed the fold times in gene
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Figure 2 The number of differentially expressed genes between infection with salmonella, SL1344 (WT, AvrA) and SB1117(AvrA-).
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Page 5 of 18expression in microarray data and real-time PCR mea-
surements at the early stage and the late stage of infec-
tion respectively. The gene expression changes
measured by qRT-PCR were in agreement with microar-
ray data.
The Pearson correction coefficient between the qRT-
PCR and microarray data was 0.836. Therefore, the
microarray provided a reliable comparison of gene
expression in mouse colon mucous sample from salmo-
nella SL1344 and SB1117 infection at 8 hours and 4
days.
Gene Ontology (GO) terms enrichment analysis for genes
differentially expressed between the SL1344 and SB1117
infection groups
The analysis of enriched GO terms could aid in inter-
preting the dominant functions controlled by differen-
tially expressed genes. To further address the potential
contribution of AvrA to the S. typhimurium SP-I TTSS-
mediated stimulation of transcriptional response in
mouse intestine, we evaluated the biological processes
for these differentially expressed genes, using the GO
term enrichment on-line analysis tool, GOEAST (Gene
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Figure 3 Real-time PCR analysis and Microarray Comparison.A :r e a l - t i m eP C Ra n a l y s i sa n dm i c r o a rray comparison at the early stage of
Infection. B: real-time PCR analysis and microarray comparison at the late stage of infection.
Liu et al. BMC Microbiology 2010, 10:326
http://www.biomedcentral.com/1471-2180/10/326
Page 6 of 18Ontology Enrichment Analysis Software Toolkit) [21].
Table 1, 2, 3, 4 lists important Gene Ontologies with
P-values less than 0.05.
In 347 up-regulated genes in the SL1344 infection
g r o u pr e l a t i v et oS B 1 1 1 7i n f e c t i o ng r o u pa t8h o u r s
(Table 1), 230 transcripts were assigned specific GO
terms. GOEAST analysis showed that most of these
genes participated in cell communication (71 genes) and
signal transduction (64 genes).
Shown in Table 2, 227 genes were down-regulated in the
SL1344 infected group relative to SB1117 infection group
at 8 hours. We found that 174 transcripts were assigned
specific GO terms. Of these transcripts, 76.6% were anno-
tated as being involved in biological processes, and a sig-
nificant number of transcripts were assigned known
functions in organelle organization (20 genes), cell cycle
(14 genes), chromosome organization (10 genes), chroma-
tin assembly and disassembly (9 genes), nucleosome
organization (9 genes), protein-DNA complex assembly
(9 genes), DNA packaging (9 genes), and cellular macro-
molecular complex assembly (9 genes). Annotation
showed that many of the genes belong to the centromere
protein and the histone family protein. This result indi-
cates that most of biological processes down-regulated by
AvrA relate to nuclear function.
In order to confirm the analysis results, we compared
the cellular component of ontology for the two groups
using the Multi-GOEAST analysis tool. As shown in
Figure 4 all of the down-regulated GO terms are asso-
ciated with the nucleus (green box), whereas up-regu-
lated processes were associated with membrane and
cytoplasm (red box). We observed a significant GO
annotation of condensed chromosome/nucleosome
related activity (red arrow in Figure 4). Therefore, we
speculate that chromosome/nucleosome process activ-
ities are strongly affected by AvrA at 8 hours post infec-
tion by SL1344.
In Table 3, 268 genes were up-regulated in the SL1344
vs SB1117 infection groups at 4 days. Among them, 134
transcripts were assigned specific GO terms. A signifi-
cant number of transcripts were assigned known func-
tions in biological regulation (70 genes), regulation of
cellular process (67 genes), multicellular organismal pro-
cess (47 genes), signal transduction (45 genes) and
apoptosis (10 genes). An interesting result was that a
total of 25 differentially expressed olfactory receptor
family members participated in all of the biological pro-
cesses except for apoptosis (Table 3).
In the SL1344 vs SB1117 infection group at 4 days,
337 genes were down-regulated genes (Table 4). Of
these gene, 201 transcripts were assigned specific GO
terms, and a significant number of transcripts were
assigned known functions in system process regulation
(39 genes), neurological system processes (37 genes),
and G protein-coupled receptor protein signaling
Table 1 List of biologic process for the up-expressed
genes in SL1344 infection group relative to that of
SB1117 infection group at 8 hr
GO ID Term No. of genes
GO:0007154 cell communication 71
GO:0007165 signal transduction 64
Table 2 List of biologic process for the down-expressed
genes in SL1344 infection group relative to that of
SB1117 infection group at 8 hr
GO ID Term No. of genes
GO:0006996 organelle organization 20
GO:0007049 cell cycle 14
GO:0051276 chromosome organization 10
GO:0006334 nucleosome assembly 9
GO:0031497 chromatin assembly and disassembly 9
GO:0034728 nucleosome organization 9
GO:0065004 protein-DNA complex assembly 9
GO:0006323 DNA packaging 9
GO:0034622 cellular macromolecular complex assembly 9
Table 3 List of biologic process for the up-expressed
genes in SL1344 infection group relative to that of
SB1117 infection group at 4 day s
GO ID Term No. of
genes
GO:0065007 biological regulation 70
GO:0050794 regulation of cellular process 66
GO:0032501 multicellular organismal process 47
GO:0007165 signal transduction 45
GO:0007154 cell communication 45
GO:0007166 cell surface receptor linked signal
transduction
38
GO:0042221 response to chemical stimulus 14
GO:0006915 apoptosis 10
GO:0008219 cell death 10
Table 4 List of biologic process for the down-expressed
genes in SL1344 infection group relative to that of
SB1117 infection group at 4 days
GO ID Term No. of
genes
GO:0003008 system process 39
GO:0050877 neurological system process 37
GO:0007186 G-protein coupled receptor protein signaling
pathway
35
GO:0007608 sensory perception of smell 27
GO:0007606 sensory perception of chemical stimulus 27
GO:0007268 synaptic transmission 7
Liu et al. BMC Microbiology 2010, 10:326
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underlie the physiological deficits of bacterial infection
by inducing a decline in gene transcription.
The ontology of the cellular component for down-
r e g u l a t e da n du p - r e g u l a t e dg e n e ss h o w e dt h a tm o s to f
molecular activity occurred in the cell membrane at 4
days post infection (data not shown).
AvrA targeted specific pathway and network analysis
An over-representation of a specific biological process
does not indicate whether the process in question is
being stimulated or repressed overall. We used IPA soft-
ware to further investigate over- or under-represented
functional activities of AvrA, specifically within the up-
regulated and down-regulated genes, at the stage of
infection at 8 hours and 4 days. We focused on the
ingenuity canonical pathways and addressed the differ-
entially up-regulated genes between the SL1344 vs
SB1117 infection groups at 8 hours and 4 days post
infection (Table 5 and Table 6).
At 8 hours post Salmonella infection, shown in Table
5 up-expression of the Ras homolog gene family, RhoB,
RhoC, RhoD and RhoU, targeted a total of 7 pathways:
cholecystokinin/gastrin-mediated signaling; CXCR4 sig-
naling; High-mobility group box 1(HMGB1) signaling;
ILK signaling; integrin signaling; phospholipase C signal-
ing; production of Nitric Oxide, and reactive oxygen
species in macrophages, and regulation of actin-based
motility by Rho. We found that these pathways are asso-
ciated with the following functions: cellular assembly
Figure 4 Graphical output of Multi-GOEAST cellular component analysis results for genes differentially expressed by SL1344 and
SB1117 infected mouse colon at 8 hours. Red Boxes represent enriched GO terms only found in up-regulated genes in the SL1344 vs SB1117
infection groups, and green boxes represent enriched GO terms only found in down-regulated genes in SB1344 vs SB1117 infection groups. The
saturation degrees of all colors represent the significance of enrichment for corresponding GO terms. Arrows represent connections between
different GO terms. Red arrows represent relationships between two enriched GO terms, black solid arrows represent relationships between
enriched and unenriched terms and black dashed arrows represent relationships between two unenriched GO terms.
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Page 8 of 18Table 5 Target pathway of up-regulated Genes in SL1344 vs SB1117 infection groups at 8 hours
Ingenuity Canonical Pathways Up-
regulated
Molecules
Cholecystokinin/Gastrin mediated Signaling 8/104 (8%) FOS, RHOV, JUN, RHOB, RHOD, IL1RN, RHOC, IL1F8
MIF Regulation of Innate Immunity 3/46 (7%) FOS, LY96, JUN
Complement System 2/36 (6%) C3, C1S
FAK Signaling 6/98 (6%) CAPN5, ARHGAP26, CAPN9, CAPN2, ITGA3, ACTC1
HMGB1 Signaling 6/98 (6%) FOS, RHOV, JUN, RHOB, RHOD, RHOC
IL-10 Signaling 4/70 (6%) FOS, JUN, IL1RN, IL1F8
Integrin 111/200
(6%)
CAPN5, RHOV, ARHGAP26, RHOB, RHOD, ITGA11, RHOC, CAPN9,
CAPN2, ITGA3, ACTC1
7/112 (6%) PLCZ1, RHOV, RHOB, RHOD, RHOC, PLCL2, CASP14
Toll-like Receptor Signaling 3/54 (6%) FOS, LY96, JUN
B Cell A ctivating Factor Signaling 2/44 (5%) FOS, JUN
Coagulation System 2/37 (5%) FGA, F3
CXCR4 Signaling 8/168 (5%) FOS, RHOV, JUN, RHOB, RHOD, RHOC, EGR1, GNG5
IL-2 Signaling 3/58 (5%) FOS, JUN, SYK
ILK Signaling 10/187(5%) MUC1, FOS, RHOV, JUN, RHOB, RHOD, RHOC, PPM1J, ACTC1, IRS3
Phototransduction Pathway 3/65 (5%) OPN3, GRK1, PDE6H
Production of Nitric Oxide and reactive Oxygen Species in
Macrophages
10/185 (5%) FOS, RHOV, JUN, RHOB, PPP1R14 D, RHOD, RHOC, PPM1J, HOXA10,
SPI1
Regulation o f Actin based 5/93 (5%) RHOV, RHOB, RHOD,
Motility by Rho RHOC, ACTC1
Role of Cytokines in Mediating Communication between
Immune Cells
3/57 (5%) IL1RN, IFNA5, IL1F8
Role of Pattern Recognition Receptors in Recognition of Bacteria
and Viruses
4/86 (5%) IRF4, C3, SYK, IFNA5
4/114 (4%) PLCZ1, FOS, JUN, PLCL2
Table 6 Target pathway of up-regulated genes in SL1344 vs SB1117 infection groups at 4 days
Ingenuity Canonical Pathways Up-regulated Molecules
Role of Cytokines in Mediating Communication between Immune Cells 3/57 (5%) IFNG, IFNA7, IL3 HS6ST1, CYP3A4, 2810007J24RIK,
LPS/IL-1 Mediated Inhibi tion of RXR f unction 5/215 (2%) IL4I1, ABCC4
Interferon Signaling 2/30 (7%) IFNG, IRF1
Retinoic acid Mediated Apoptosis Signaling 2/44 (5%) CFLAR, IRF1
IL-12 Signaling and Pro duction in m acrophages 3/134 (2%) IFNG, IF NA7, IRF1
Ga12/13 Signaling 3/126 (2%) BTK, F2RL2, MEF2D
Calcium -induced T Lymphocyte Apoptosis 2/65 (3%) MEF2 D, ORAI1
Prolactin Signaling 2/75 (3%) SOCS3, IRF1
VDR/RXR Activation 2/80 (3%) IFNG, RUNX2
Acute Phase Response Signaling 3/178 (2%) SOCS3, TF, IL6R
Role of NFAT in Regulation of the Immune response 3/195 (2%) BTK, MEF2 D, ORAI1
Communication between Innate and adaptive Immune Cells 2/90 (2%) IFNG, IL3
Fc Epsilon RI Signaling 2/103 (2%) BTK, IL3
Natural Killer Cell Signaling 2/112 (2%) KLRK1, HCST
IL-22 Signaling 1/28 (4%) SOCS3
IL-15 Production 1/31 (3%) IRF1
p70S6K Signaling 2/131 (2%) BTK, F2RL2
IL-9 Signaling 1/37 (3%) SOCS3
JAK/Stat Signaling 1/64 (2%) SOCS3
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Page 9 of 18and organization, cell to cell signaling and interaction,
and infectious diseases.
Furthermore, we found that the up-regulated genes
Fas and Jun, as transcription regulators, co-targeted
many of pathways which are implicated as regulators of
the stress response (production of Nitric Oxide and
Reactive Oxygen Species in Macrophages pathway, IL-2
Signaling pathway, Toll-like Receptor Signaling, and
CXCR4 Signaling pathway), inflammation (HMG1 path-
way), proliferation (Cholecystokinin/Gastrin-mediated
Signaling) and cell apoptosis (14-3-3 mediated signaling
B Cell Activating Factor Signaling).
To clarify AvrA function in interactions between up-
regulated genes, we examined gene networks using IPA.
A ss h o w ni nF i g u r e5t h i sn e t w o r kp r e s e n t e dI L 1 R N ,
NF-B, and IL1 in central positions and corrected the
following functions: Cellular assembly and organization,
infectious disease, and tissue morphology. Based on the
Ingenuity Pathway Knowledge base, around the NF-B
central position, IL1F8, IFNA and IL1RA decrease NF-
B activation, whereas LY96, TNFRSF12A, SAA2, and
Fibrinogen increase NF-B activation. This result
showed that AvrA is involved in regulation of NF-B
activation. However, AvrA’s role in modulating the NF-
B activity may depend on a complex regulation
network.
As shown in Figure 6 the network also showed the
relevance of the Ras homolog, EGR1 group, Fas group
and Jun group. In mouse M1 cell lines, EGR1 protein
increases expression of mouse Junb mRNA [30]. The
Salmonella Typhimurium type III Secretion effectors,
SopE, SopE2 and SopB, stimulate Rho-family GTPase
signaling [31,32] and innate immune responses [33,34].
Our study demonstrate that AvrA stabilizes the tight
Peptidase
Transporter
Cytokine Enzyme Unknown
Receptor Transcription regulator
Figure 5 Ingenuity pathway Analysis network 1 depicting relationships among up-regulated genes in SB300 infection group relative
to that of SB1117 infection group at 8 hours. Intensity of the red color indicates the degree of up-regulation. Nodes are displayed using
various shapes that represent the functional class of the gene product. Edges are displayed with various labels that describe the nature of
relationship between the nodes: ___ represents direct relationship; ——— represents indirect relationship; ® represents acts on.
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Page 10 of 18junction structure and protein expression in vitro and
in vivo [35]. Studies on AvrA demonstrated that AvrA
reverses the activation of specific signaling pathways
induced by effectors delivered by S.T y p h i m u r i u mvia
the same TTSS [9]. Hence, the AvrA may have opposite
effects on Rho-family GTPase, whereas the other Salmo-
nella effectors stimulate Rho-family GTPase signaling.
Down-expressed genes in SL1344 vs SB1117 infection
groups at 8 hours targeted mainly nuclear receptor sig-
naling related pathway, such as PXR/RXR Activation,
FXR/RXR Activation, and LPS/IL-1 Mediated Inhibition
of RXR Function (Additional file 4 Table S4). The three
pathways were co-targeted by the protein product of
three genes, Cyp2c8 (Cytochrome P4502C8), Aldha1
(Aldehyde dehydrogenase 1 family, member A1), and
Prkag2 (5’-AMP-activated protein kinase subunit
gamma-2). We also observed decreased expression of
the gene for Fancd2 in the SL1344 infection group rela-
tive to SB1117 infection group. This protein is monou-
biquinated in response to DNA damage, resulting in its
localization to nuclear foci with other proteins (BRCA1
and BRCA2) involved in homology-directed DNA repair
[36-38]. In other words, the down-regulation of Fancd2
in the SL1344 infection group relative to the control
group implies that AvrA protects from DNA damage at
the early stage of SL1344 infection. We also found that
Socs2, which encodes a member of suppressors of cyto-
kine signaling [39], is down-regulated in the SL1344 vs
the SB1117 infection group. The Socs2 protein interacts
with the cytoplasmic domain of insulin-like growth
Peptidase
Transporter
Cytokine Enzyme Unknown
Receptor Transcription regulator
Figure 6 Ingenuity Pathway Analysis Network 2 depicting relationship among up-regulation Genes in SL1344 vs SB1117 infection
groups at 8 hours. Intensity of the red color indicates the degree of up-regulation. Nodes are displayed using various shapes that represent
the functional class of the gene product. Edges are displayed with various labels that describe the nature of relationship between the nodes:
___ represents direct relationship, ——— represents indirect relationship ® represents acts on.
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Page 11 of 18factor 1 receptor (IGF1R), and thus regulating IGF1R
mediated cell signaling [39].
In addition, as shown in Additional file 3 Table S3,
Socs2 also targeted JAK pathway signal transduction
adaptor activity and participated in regulation of cell
growth and anti-apoptosis. Because Socs2 is a negative
regulator of cytokine signal transduction that inhibits
the JAK/STAT pathway [40,41], the increased levels of
the genes in the SL1117 infection group relative to con-
trol and SL1344 infection group may help to explain
AvrA’s proliferation role in activating JAK/STAT path-
way at the early stage of SL1344 infection.
At 4 days post Salmonella infection, 5 up-regulated
expressed genes in SL1344 infection group, compared to
SB1117 infection group, overlap with a series of canoni-
cal pathways (Table 6): Ifng, Irf1, Btk, Mef2 d, and Socs3.
These pathways have been associated with the following
functions: cellular movement, the hematological system,
cell proliferation and the hematopoiesis. Interferon-
gamma (IFNG) is a cytokine critical for innate and
adaptive immunity against viral and intracellular bacter-
ial infections and for tumor control [42,43]. This result
indicated that at the later stage of Salmonella infection
AvrA may be involved in regulation of aberrant IFNG
expression, which is associated with a number of autoin-
flammatory and autoimmune diseases.
We observed that another suppressor of cytokine sig-
naling, Socs3, is up-regulated in the SL1344 vs. SB1117
infection groups at 4 days postinfection. This result con-
trasts with the down-expressed status of Socs2 at
8 hours. As shown in Table 6 the expression of Socs3
through the JAK/STAT pathway negatively regulates
cytokine signaling, e.g., signaling of rolactin, acute phase
response, IL-9, and IL-22. We found that these pathways
are related to cell death; cellular growth and prolifera-
tion; as well as gastrointestinal and inflammatory dis-
ease. This finding suggests a possible role for AvrA that
affects the above functions and diseases through regula-
tion of cytokine signaling.
Down-expressed genes in the SL1344 vs. the SB1117
infection groups at 4 days targeted mainly metabolic
related pathways, such as aminophosphonate, histideine
and cysteine metabolism (Additional file 5 Table S5).
The protein product of Prmt5, which is the protein
arginine methyltransferase 5 involved in protein modifi-
cation, targets these three pathways. As shown in
Table S5, Casq1, Chrna4,a n dRyrs are related to cal-
cium signaling, and they are down-regulated in SL1344
vs. the SB11117 infection groups, but showed almost
unchanged expression in the SL1344 infection group
relative to the control. This result implies that AvrA
negatively regulates calcium signaling in the late stage of
SL1344 infection.
AvrA function analysis during the time course of SL1344
We further used the canonical pathway analysis software
package in IPA software to determine whether and to
what extent a given pathway is affected by the bacteria
effector AvrA. We found many pathways with different
signaling responses during the early and late stage of
SL1344 and SB1117 infection. Figure 7 lists the nine
representative pathways yielded by this analysis.
The mTOR signaling, Myc-mediated cell apoptosis
signaling, PDGF, VEGF, JAK-STAT, and LPS-stimulated
MAPK signaling were most significant at the stage of
SL1344 infection compared to SB1117 infection after 4
days (Figure 7). However, these pathways were less sig-
nificant at the early stage of SL1344 and SB1117 infec-
tion (8 hours). Hence, this analysis confirmed the
functional performance of AvrA in late stage of SL1344
infection. We also found that these above pathways
were closely related to biological processes of cell apop-
tosis. These observations are consistent with the signal-
ing transduction studied on AvrA in anti-apoptosis
[7,8]. Therefore, AvrA plays an essential role in anti-
apoptosis by regulating multiple signaling pathways
in vivo.
Unlike the above pathways, oxidative phosphorylation
showed the most significant signaling at the early stage
of SL1344 vs. SB1117 infection. Our results also showed
that AvrA had no important function in regulating oxi-
dative phosphorylation pathway at the late stage of
infection (Figure 7 Oxidative phosphorylation).
NF-B signaling is a key player in inflammation
[44,45]. We found that NF-B was less significant in
SL1344 vs. SB1117 infection at early stage of infection,
but at the late stage of SL1344 infection, NF-B signal-
ing showed higher significance than that of SB1117
infection (Figure 7). Post-transcriptional study demon-
strated that AvrA inhibits the NF-B activity though
stabilizing the inhibitor of NF-B, IBa [6,8]. Overall,
this result implies that AvrA suppressed the NF-B
activity at the early stage of SL1344 infection and has a
different regulatory role at the late stage.
In contrast, the significance values of SAPK/JNK sig-
naling were low at late stages of SB1117 infection,
which suggest that SL1117 infection is not associated
with the SAPK/JNK pathway at the late stage of
Infection.
AvrA regulation of the mTOR, NF-B, JNK, and oxidative
phosphorylation signaling pathways in vivo
It is possible that the genes that underlie the biology of
ap a t h w a yc o u l db ed i f f e r e n tf r o mo n eo b s e r v a t i o nt o
another, even if the significant values remain unchanged.
To evaluate this possibility, we performed a cross-
analysis comparison of the genes associated with a given
Liu et al. BMC Microbiology 2010, 10:326
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Page 12 of 18pathway during the early and late stages of SL1344 and
SB1117 infection. To further analyze the AvrA regula-
tion of the mTOR, NF-B, JNK, and oxidative phos-
phorylation signaling pathways in vivo, we generated
heat maps to investigate the associated genes in these
pathways (Figure 8A-D).
A ss h o w ni nF i g u r e8 A ,m a n yg e n e so fm T O Rp a t h -
way play a role in cell proliferation, migration, apoptosis,
differentiation, growth, and cell death. VEGFA,
PIK3C2A, PIK3CD, PIK3C2G,a n dPRKCH showed up-
regulation in the SL1344 infection group at the late
stage of infection, whereas in the SB1117 infection
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Figure 7 Canonical pathways identified by IPA associated with SL1344 and SB1117 responsive genes.
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Page 14 of 18group, the expression of these genes showed no signifi-
cant change. These data indicated that AvrA is involved
in the mTOR signaling pathway, thus playing a role in
proliferation and apoptosis.
Figure 8B showed that Card10 was up-regulated at the
early stage of SB1117 infection, but not at the early
stage of SL1344 infection. The Card10 protein is a cas-
pase recruitment domain/membrane-associated guany-
late kinase family that interacts with BCL10 and
activates NF-B-inducing kinase activity [46]. Hence,
the result showed that AvrA may inhibit NF-Ba c t i v a -
tion at the early stage of SL1344 infection relative to
SB1117 infection. However, at the late stage of infection,
many genes were differentially expressed between the
SL1344 vs. SB1117 infection groups. These genes
including down-regulated KRAS, PIK3R1, PDGFRB,
CHR, CHUK and CSNKIA1,a sw e l la su p - r e g u l a t e d
genes T L R 4 ,T L R 3a n dT L R 7 ,E I F 2 A K 2 ,T B k 1 ,a n d
PIK3C2A. Because the listed genes are involved in both
negative and positive regulation for NF-B activation
respectively, AvrA function for the NF-B pathway was
more complex at the late stage of SL1344 infection.
We observed that Dusp10 is up-regulated at 8 hours
post SB1117 infection, but no expression change was
observed at 8 hours post SL1344 infection (Figure 8C).
Because DUSP10 negatively regulates JNK and
p38MAPK [47,48], we reasoned that AvrA may stabilize
DUSP10 expression to inhibit activation of JNK pathway
at the early stage of SL1344 infection. However, more
up-regulated and down-regulated genes that participate
in response to the MAPKK signaling cascade are
involved at the late stage of both SL1344 and SB1117
infection, there is no clear evidence that AvrA functions
differently in the SAPK/JNK pathway at the late stage.
Figure 8D listed genes involved with oxidative phosphor-
ylation at 8 hours post SL1344 infection, compared to the
same time post SB11117 infection. These genes included
ATP synthase family members (ATP5E, ATP5I,a n d
ATP6V1), cytochrome C oxidase family members (Cox6A1
and Cox6B1), NADH dehydrogenase family members
(NDUFA1, NDUFAB, NDUFB3, NDUDB1and NDUFS5),
and Ubiquinol-cytochrome-c reductase family members
(URCR and URCARH). The oxidative phosphorylation
pathway covers a series of oxygen and redox reactions
within mitochondria. AvrA may be involved in regulation
of mitochondrial function at the early stage of infection.
Comparison the role for AvrA in microarray analysis with
previous study
As shown in Table 7 several previous studies have
reported that AvrA functions in these pathways, includ-
ing JNK, NF-B, p53, b-catenin, and tight-junction sig-
naling. Similar to the previous results, our microarray
analysis for AvrA role at the early stage of infection
further reveal that AvrA can lead to gene expression
changes of JNK and NF-B pathway. Moreover, our
study extended the understanding of AvrA in inhibiting
the JNK and NF-B pathways.
However, the microarray study has its limitations to
identify the post-transcriptional and posttransductional
behavior of the differentially expressed genes. This
method may also have statistical error. We have demon-
strated that Salmonella effector AvrA can activate
b-catenin pathway through deubiquitination [8]. How-
ever, the activated pathway was not reveled in the cur-
rent analysis. Hence, further studies combined genomic
and proteomic are necessary to explore further details of
AvrA function in interplaying with host cell.
Conclusion
In this study, we have used DNA microarrays to define
the molecular regulators of intestinal signaling and host
Table 7 Summary of publications regarding the role for Salmonella AvrA in monolayers, drosophila, and mouse
models.
Models Pathways References
Monolayers Tight-junction pathway Liao et al., PLoS One. 2008 3(6):e236
Activated b-catenin pathway Sun et al., Am J Physiol Gastrointest Liver Physiol. 2004 287(1):G220-7
Inhibited NF-B pathway Ye et al., Am J Pathol. 2007 171(3):882-92
Inhibited NF-B pathway Collier-Hyams et al., J Immunol. 2002 169(6):2846-50
Inhibited JNK pathway Du and Galan, PLoS Pathog. 20095(9): e1000595
Inhibited JNK pathway Jones et al, Cell Host Microbe. 2008 3(4):233-44
Drosophila Inhibited JNK, NF-B pathway Jones et al, Cell Host Microbe. 2008 3(4):233-44
Mouse Inhibited JNK, NF-B pathway Jones et al, Cell Host Microbe. 2008 3(4):233-44
Inhibited NF-B pathway Ye et al., Am J Pathol. 2007 171(3):882-92
Activated P53 pathway Wu et al., Am J Physiol Gastrointest Liver Physiol. 2010 298(5):G784-94.
Tight-junction pathway Liao et al., PLoS One. 2008 Jun 4;3(6):e236
Activated b-catenin pathway b Ye et al., Am J Pathol. 2007 Sep;171(3):882-92
Activated Wnt/b-catenin Pathway Liu et al., FEBS Letter, 2010 584(5):911-916
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Page 15 of 18defense expressed in adult C57Bl/6 female mice during
the early and late phases of infection with virulent
SL1344 (AvrA+) or isogenic AvrA-Salmonella strains.
We identified pathways, such as mTOR signaling, oxida-
tive phosphorylation, NF-B, VEGF, JAK-STAT, and
MAPK signaling regulated by AvrA in vivo, which are
associated with inflammation, anti-apoptosis and prolif-
eration. At the early stage of Salmonella infection,
down-regulated genes in the SL1344 vs SB1117 infection
groups mainly targeted pathways related to nuclear sig-
naling and up-regulated genes in the SL1344 vs SB1117
infection groups mainly targeted oxidative phosphoryla-
tion. At the late stage of Salmonella infection, AvrA
inhibits Interferon-gamma responses. Both early and late
phases of the host response exhibit remarkable specifi-
city for the AvrA+ strain in intestine. These results pro-
vide new insights into the molecular cascade, which is
mobilized to combat Salmonella-associated intestinal
infection in vivo.
Our in vivo data indicated that the status of AvrA in
Salmonella strains may alter the strains’ ability to induce
host responses, especially in the intestinal mucosa
response. Our recent study on AvrA further demon-
strates that AvrA enhances intestinal proliferation
in vivo [18,49]. Although the exact function and
mechanism of AvrA is not entirely clear, it is known
that AvrA is a multifunctional protease that influences
eukaryotic cell pathways that utilize ubiquitin and acety-
lation, thus inhibiting apoptosis and promoting intest-
inal proliferation [7,8].
Our microarray data analysis indicated that NF-Bi s
one of the top-10 signaling pathways targeted by AvrA
in vivo. A recent study showed that AvrA inhibits the
Salmonella-induced JNK pathway but showed a very
weak inhibition of the NF-B signaling [9]. The different
findings about the AvrA’s regulation of the NF-B path-
way may be due to the different experimental system
used and different stage post infection. Because the NF-
B is centrally involved of inflammatory networking,
other functions of AvrA may indirectly influence the
NF-B activity [35,50].
AvrA status affects levels of expression of the other
effector proteins in Salmonella ([51] and unpublished
data). Stimulation of inflammation by bacterial effectors
is crucial for Salmonella to grow in the intestine [52,53].
However, un-controlled inflammation is harmful to the
host and eventually damages the niche involved Salmo-
nella growth. AvrA plays a role opposite to that of the
other known effectors by inhibiting the inflammatory
responses in intestine. Hence, one could argue that
AvrA’s role in inhibiting inflammation allows the patho-
gen to survive well in the host, thus establishing a
mutually beneficial relationship.
Our current study investigated gene expression at the
mRNA level in response to AvrA. Posttranscriptional
modification by AvrA cannot be identified by DNA
array analysis. Study using Western blot and other pro-
tein assay methods will provide further insights into the
AvrA’s regulation of eukaryotic proteins in intestine.
Taken together, our findings show that AvrA specifi-
cally inhibits inflammatory responses and promotes pro-
liferation in vivo. It is important to understand how
AvrA works in vivo because of the Salmonella problems
and the bioweapon threat of bacterial toxins. We believe
that studies on the action of bacterial effectors will
uncover new facets of bacterial-host interaction that
may lead to the development of new therapeutic drugs
or vaccines against important human pathogens.
Additional material
Additional file 1: Table S1. Primer sequence for qRT-PCR. Listing all
primer sequences used in qRT-PCR (PDF file). PCR data were shown in
Figure 3.
Additional file 2: Table S2. Differentially expressed genes between
the SL1344 infection and the SB1117 infection at early stage. The
list of differentially expressed genes between the SL1344 infection and
the SB1117 infection at 8 hours post-infection (P ≤ 0.05 with fold
change≥1.2 or ≤-1.2).
Additional file 3: Table S3. Differentially expressed genes between
the SL1344 infection and the SB1117 infection at late stage. The list
of differentially expressed genes between the SL1344 infection and the
SB1117 infection at 4 days post-infection (P ≤ 0.05 with fold change≥1.2
or ≤-1.2).
Additional file 4: Table S4. Target pathway of down-regulated
genes in SL1344vs SB1117 infection group at 8 hours. Listing target
pathway of down-regulated genes in SL1344vs SB1117 infection group at
8 hours post-infection.
Additional file 5: Table S5. Target pathway of down-regulated
genes in SL1344 vs SB1117 infection group at 4 days. Listing target
pathway of down-regulated genes in SL1344vs SB1117 infection group at
4 day post-infection.
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